InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
64,196.05
(
0.48%
)
Post# of 251718
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

dav1234

Send PM Follow Ignore
Followers 97
Posts 92809
Boards Moderated 4
Alias Born 10/29/2007

dav1234

Re: None

Thursday, 03/27/2014 8:25:08 AM

Thursday, March 27, 2014 8:25:08 AM

Post# of 251718
Alimera resubmits NDA
Alimera Sciences (ALIM) resubmits its NDA for ILUVIEN after receiving a CRL from the regulator in October.
The product is approved for sale in the UK, Portugal, France, Germany and Spain, but is commercially available only in the UK and Germany.
Consensus revenue estimates for 2014 and 2015 are $13.7M and $36.2M, respectively.
73 mutual funds have positions, up from 23 a year earlier.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up